A Study in Patients With Diabetes Mellitus Type II of the Effect on Albuminuria of 24 Week Treatment With Valsartan, Benazepril, and Valsartan+Benazepril

NCT00171119 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

81

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension
Diabetic Nephropathy

Interventions

DRUG: valsartan

Sponsor

Novartis Pharmaceuticals